I believe the Avant website has been updated (haven't looked there in ages).
Now english is not my native language but it seems from how i read it that Gerald is perhaps no longer a part of AMBS?
They seem to talk in the past sense and his profile seems updated, at least i never noticed this before?
This is new right or am my eyes deceiving me?
http://ir.avantdiagnostics.com/board-of-directors
Now english is not my native language but it seems from how i read it that Gerald is perhaps no longer a part of AMBS?
They seem to talk in the past sense and his profile seems updated, at least i never noticed this before?
This is new right or am my eyes deceiving me?
http://ir.avantdiagnostics.com/board-of-directors
Quote:Gerald Commissiong
Director
Mr. Commissiong has served as the Chief Operating Officer and a Director of Amarantus Biosciences Holdings, Inc. since April of 2011. On October 23, 2011, Mr. Commissiong was appointed to serve as Amarantus' Chief Executive Officer and President. Mr. Commissiong was the co-founder and President and Chief Executive Officer of Amarantus , which was formerly known as CNS Protein Therapeutics, Inc. He played a significant role in sourcing the seed funding for the Company in 2008, assisted in developing a strategic corporate development pathway that involved the recruitment of relevant expertise, identification of appropriate development strategy, liaising with expertise to define development pathway, creation of a technological mitigation strategy and the identification of appropriate funding partners with a strategic interest in the Company's technology. Mr. Commissiong also recruited senior executives to the board to guide Amarantus' growth and generated its official marketing materials, including investor brochures, corporate handouts, email newsletters and other materials necessary to raise awareness of the company. Prior to co-founding Amarantus, Mr. Commissiong played professional football for the Calgary Stampeders of the Canadian Football League. Mr. Commissiong holds a B.S. degree in Management Science and Engineering with a focus on Financial Decisions from Stanford University.
2
